Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against Malaria

Mostrar otras versiones (1)

Protecting against both liver and blood stages of infection is a long-sought goal of malaria vaccine design. Recently, we described the use of replication-defective viral vaccine vectors expressing the malaria antigen merozoite surface protein-1 (MSP-1) as an antimalarial vaccine strategy that elici...

Descripción completa

Detalles Bibliográficos
Autores principales: Draper, Simon J., Goodman, Anna L., Biswas, Sumi, Forbes, Emily K., Moore, Anne C., Gilbert, Sarah C., Hill, Adrian V.S.
Formato: Texto
Lenguaje:English
Publicado: Cell Press 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663714/
https://www.ncbi.nlm.nih.gov/pubmed/19154991
http://dx.doi.org/10.1016/j.chom.2008.12.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663714/
https://www.ncbi.nlm.nih.gov/pubmed/19154991
http://dx.doi.org/10.1016/j.chom.2008.12.004

Ejemplares similares